THE CLINICAL-PHARMACOLOGY OF METHOTREXATE

被引：113

作者：

SCHORNAGEL, JH ^{[1
]}

MCVIE, JG ^{[1
]}

机构：

[1] NETHERLANDS CANC INST,CLIN RES UNIT,1066 CX AMSTERDAM,NETHERLANDS

来源：

关键词：

D O I：

10.1016/S0305-7372(83)80032-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：53 / 75

页数：23

共 50 条

[1] CLINICAL-PHARMACOLOGY OF METHOTREXATE
BERTINO, JR
[J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (04): : 401 - 411
[2] CLINICAL-PHARMACOLOGY OF METHOTREXATE
CHABNER, BA
DONEHOWER, RC
SCHILSKY, RL
[J]. CANCER TREATMENT REPORTS, 1981, 65 : 51 - 54
[3] CLINICAL-PHARMACOLOGY OF METHOTREXATE - PHARMACOKINETICS OF HIGH-DOSE ORAL METHOTREXATE
MATSUOKA, H
SASAKI, K
FUJIMOTO, T
[J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 404 - 404
[4] CLINICAL-PHARMACOLOGY OF INTERMEDIATE-DOSE ORAL METHOTREXATE
SMITH, DK
OMURA, GA
OSTROY, F
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 4 (02) : 117 - 120
[5] CLINICAL-PHARMACOLOGY
STERN, RS
[J]. ARCHIVES OF DERMATOLOGY, 1993, 129 (03) : 347 - 347
[6] CLINICAL-PHARMACOLOGY
HORTON, EW
[J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 1981, 25 (01): : 102 - 102
[7] CLINICAL-PHARMACOLOGY
REIDENBERG, MM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (02): : 192 - 194
[8] CLINICAL-PHARMACOLOGY
BURKS, TF
[J]. ARIZONA MEDICINE, 1982, 39 (06) : 393 - 394
[9] CLINICAL-PHARMACOLOGY
GUNDERTREMY, U
WEBER, E
[J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1984, 126 (26): : 839 - 840
[10] CLINICAL-PHARMACOLOGY
SMITH, JG
[J]. ARCHIVES OF DERMATOLOGY, 1993, 129 (07) : 908 - 908